Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Photo not available

Jyotsna R. Sandil, M.D.

Regulatory Affairs Specialist
Regulatory Affairs Branch
NCI DCTD - Cancer Therapy Evaluation Program
240-276-7274
|
Jyotsna.sandil@nih.gov

Dr. Jyotsna Sandil joined the Drug Regulatory Group of the Regulatory Affairs Branch at CTEP in March 2023. She manages the Investigational New Drug Applications (IND) for a complex portfolio of the investigational agents and facilitates FDA communications related to that portfolio. She provides regulatory support to CTEP, NCI, investigators, and pharmaceutical collaborators.

Dr. Sandil received her M.D. from Kuban State Medical Academy in Russia. She worked as a medical resident officer in India. In the U.S., she served as a clinical research coordinator and senior clinical research manager for over a decade prior to joining CTEP, preparing IRB submissions, protocol revisions, and renewals, and ensuring institutional compliance with FDA and USDA regulations.

Email